Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Long-Term Protocols: The most clinically relevant studies evaluated subcutaneous doses of 0.25 mg (250 mcg), 0.5 mg (500 mcg), and 1 mg (1,000 mcg) administered daily for 24 weeks
doi: 10.3389/fphar.2023.1196287 Received 29 March 2023 Accepted 02 May 2023 Published 15 May 2023 Volume 14 - 2023 Edited by Daniela Gabbia, University of Padova, Italy Reviewed by Xiao Li, Shandong Provincial Qianfoshan Hospital, China Hartmut Kuhn, Charit University Medicine Berlin, Germany Updates Copyright 2023 Lu, Hu, Chen, Li, Yuan, Tian, Cao and Qiu
* Import taxes
Every serum includes a free microneedling accessory for optional targeted scalp use
Off-label prescribing under physician oversight BPC-157 is not FDA-approved
Koch HM, Preuss R, Angerer J
